Somatostatin Receptor Type Market
Global Somatostatin Receptor Type Market Size, Share & Trend Analysis Report by Type (SSTR 1, SSTR 2A, SSTR 2B, SSTR 3, SSTR 4, and SSTR 5), by Application (Alzheimer’s Disease, Cancer, and Hormonal Disorder), Forecast (2022-2028) Update Available - Forecast 2024-2030
The global somatostatin receptor type market is expected to grow at a considerable CAGR during the forecast years. Somatostatin is the hormone that regulates various physiological functions in the human body. Somatostatin is produced by several tissues mostly of the digestive system and nervous system. Furthermore, it also inhibits the rapid production of normal or tumor cells. One of the key factors for the growth of the market is the increasing number of cancer patients due to which demand for the somatostatin receptor type is expected to increase, as the somatostatin receptor type actively inhibits cell proliferation. According to a report by World Health Ord. (WHO) in 2020, cancer is found to be the most common cause of death with around 10 million deaths in 2020. The rising number of cancer patients is expected to drive the demand for somatostatin receptor types resulting in the growth of the global somatostatin receptor type market.
Impact of COVID-19 on Global Somatostatin Receptor Type Market
COVID-19 has impacted the global economy due to a slowdown in the manufacturing of various industries. The somatostatin receptor type market also declined as the manufacturing of somatostatin receptor antagonists decreased due to the slowdown of the therapeutics processes in hospitals.
Segmental Outlook
The global somatostatin receptor type market is segmented based on type and application. Based on type, the market is sub-segmented into SSTR 1, SSTR 2A, SSTR 2B, SSTR 3, SSTR 4, and SSTR 5. Based on application, the market is sub-segmented into Alzheimer’s disease, cancer, and hormonal disorder. Among these, SSTR 1 type segment is expected to hold prominent shares among the global somatostatin receptor type market as SSTR 1 dominates in thyroid gland and hyperplasia, and can be used for the treatment of thyroid tumors.
Global Somatostatin Receptor Type Market by Application, 2021(%)
The Alzheimer’s Disease Segment is Anticipated to Hold a Major Share in the Global Somatostatin Receptor Type market.
The somatostatin receptor type application for the Alzheimer’s disease segment is expected to hold a major share in the global somatostatin receptor type market due to increasing cases of Alzheimer’s disease globally. Alzheimer’s disease is a neurological disorder in which the brain gets shrink and brain cells die. There are several effects a person has to face due to Alzheimer’s disease including loss of memory and confusion in doing other mental activities. According to an article published by Bright Focus Foundation on July 14, 2021, around 50 million people had Alzheimer’s disease. The number of patients suffering from Alzheimer’s disease is increasing and is expected to exceed 152 million by 2050. The increasing number of Alzheimer’s disease patients is driving the demand for somatostatin receptor type for the treatment which in turn is expected to grow the segment in the global somatostatin receptor type market.
Regional Outlooks
The global Somatostatin Receptor Type market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa, and Latin America). The North American region is expected to hold the major share in the global somatostatin receptor type market due to the presence of several key players in the region.
Global Somatostatin Receptor Type Market Growth by Region, 2022-2028
The Asia Pacific Region is Expected to Grow at a Significant CAGR among the Global Somatostatin Receptor Type Market During Forecast Year.
The Asia Pacific regional somatostatin receptor type market is anticipated to grow at a significant CAGR during the forecast year due to the increasing number of people with cancer. Somatostatin receptor types can be used for the treatment of cancer as they inhibit the production of cancer cells during therapy. According to a report published on JCO Global Oncology by National Cancer Registry Programme, India, there were around 1.39 million new patients diagnosed with cancer in 2020. The increasing number of cancer patients in Asia Pacific countries such as India has increases the demand for the somatostatin receptor type in the region resulting in the growth of the Asia Pacific regional somatostatin receptor type market.
Market Players Outlook
The major companies serving the global somatostatin receptor type market include Chiasma, Inc., GlaxoSmithKline plc, Merck Group, Novartis International AG, Peptide Logic LLC, and many others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, fundings, and new product launches. For instance, in June 2020, the US Food and Drug Administration (FDA) approved octreotide capsules ‘MYCAPSSA’ by chiasma, Inc. These capsules can be used for the long-term treatment of patients suffering from acromegaly.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global Somatostatin Receptor Type market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on The Global Somatostatin Receptor Type Market
• Recovery Scenario of Global Somatostatin Receptor Type Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Chiasma, Inc.
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. GlaxoSmithKline plc.
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Merck Group
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Novartis International AG
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Peptide Logic LLC
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Key Strategy Analysis
3.7. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global Somatostatin Receptor Type Market by Type
4.1.1. SSTR 1
4.1.2. SSTR 2A
4.1.3. SSTR 2B
4.1.4. SSTR 3
4.1.5. SSTR 4
4.1.6. SSTR 5
4.2. Global Somatostatin Receptor Type Market by Application
4.2.1. Alzheimer’s Disease
4.2.2. Cancer
4.2.3. Hormonal Disorder
5. Regional Analysis
5.1. North America
5.1.1. The US
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Pfizer Inc.
6.2. Bristol Myers Squibb (BMS)
6.3. Strongbridge Biopharma
6.4. Amryt Pharma plc
6.5. Daewoong Pharmaceuticals Co. Ltd.
6.6. Ipsen
6.7. Lantheus Medical Imaging
6.8. Zucara Therapeutics
6.9. AstraZeneca group Co.
6.10. Eli Lilly and Co.
6.11. F. Hoffmann-La Roche Ltd.
6.12. Sanofi SA
6.13. Teva Pharmaceuticals Industries Ltd.
1. GLOBAL SOMATOSTATIN RECEPTOR TYPE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
2. GLOBAL SSTR 1 SOMATOSTATIN RECEPTOR TYPE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL SSTR 2A SOMATOSTATIN RECEPTOR TYPE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL SSTR 2B SOMATOSTATIN RECEPTOR TYPE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL SSTR 3 SOMATOSTATIN RECEPTOR TYPE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL SSTR 4 SOMATOSTATIN RECEPTOR TYPE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7. GLOBAL SSTR 5 SOMATOSTATIN RECEPTOR TYPE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL SOMATOSTATIN RECEPTOR TYPE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
9. GLOBAL SOMATOSTATIN RECEPTOR TYPE FOR ALZHEIMER’S DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL SOMATOSTATIN RECEPTOR TYPE FOR CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11. GLOBAL SOMATOSTATIN RECEPTOR TYPE FOR HORMONAL DISORDER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12. GLOBAL SOMATOSTATIN RECEPTOR TYPE MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
13. NORTH AMERICAN SOMATOSTATIN RECEPTOR TYPE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
14. NORTH AMERICAN SOMATOSTATIN RECEPTOR TYPE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
15. NORTH AMERICAN SOMATOSTATIN RECEPTOR TYPE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
16. EUROPEAN SOMATOSTATIN RECEPTOR TYPE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
17. EUROPEAN SOMATOSTATIN RECEPTOR TYPE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
18. EUROPEAN SOMATOSTATIN RECEPTOR TYPE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
19. ASIA-PACIFIC SOMATOSTATIN RECEPTOR TYPE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
20. ASIA-PACIFIC SOMATOSTATIN RECEPTOR TYPE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
21. ASIA-PACIFIC SOMATOSTATIN RECEPTOR TYPE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
22. REST OF THE WORLD SOMATOSTATIN RECEPTOR TYPE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
23. REST OF THE WORLD SOMATOSTATIN RECEPTOR TYPE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
24. REST OF THE WORLD SOMATOSTATIN RECEPTOR TYPE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL SOMATOSTATIN RECEPTOR TYPE MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL SOMATOSTATIN RECEPTOR TYPE MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL SOMATOSTATIN RECEPTOR TYPE MARKET, 2021-2028 (%)
4. GLOBAL SOMATOSTATIN RECEPTOR TYPE MARKET SHARE BY TYPE, 2021 VS 2028 (%)
5. GLOBAL SSTR 1 SOMATOSTATIN RECEPTOR TYPE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL SSTR 2A SOMATOSTATIN RECEPTOR TYPE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL SSTR 2B SOMATOSTATIN RECEPTOR TYPE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8. GLOBAL SSTR 3 SOMATOSTATIN RECEPTOR TYPE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL SSTR 4 SOMATOSTATIN RECEPTOR TYPE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10. GLOBAL SSTR 5 SOMATOSTATIN RECEPTOR TYPE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11. GLOBAL SOMATOSTATIN RECEPTOR TYPE MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
12. GLOBAL SOMATOSTATIN RECEPTOR TYPE FOR ALZHEIMER’S DISEASE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13. GLOBAL SOMATOSTATIN RECEPTOR TYPE FOR CANCER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14. GLOBAL SOMATOSTATIN RECEPTOR TYPE FOR HORMONAL DISORDER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
15. GLOBAL SOMATOSTATIN RECEPTOR TYPE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
16. US SOMATOSTATIN RECEPTOR TYPE MARKET SIZE, 2021-2028 ($ MILLION)
17. CANADA SOMATOSTATIN RECEPTOR TYPE MARKET SIZE, 2021-2028 ($ MILLION)
18. UK SOMATOSTATIN RECEPTOR TYPE MARKET SIZE, 2021-2028 ($ MILLION)
19. FRANCE SOMATOSTATIN RECEPTOR TYPE MARKET SIZE, 2021-2028 ($ MILLION)
20. GERMANY SOMATOSTATIN RECEPTOR TYPE MARKET SIZE, 2021-2028 ($ MILLION)
21. ITALY SOMATOSTATIN RECEPTOR TYPE MARKET SIZE, 2021-2028 ($ MILLION)
22. SPAIN SOMATOSTATIN RECEPTOR TYPE MARKET SIZE, 2021-2028 ($ MILLION)
23. REST OF EUROPE SOMATOSTATIN RECEPTOR TYPE MARKET SIZE, 2021-2028 ($ MILLION)
24. INDIA SOMATOSTATIN RECEPTOR TYPE MARKET SIZE, 2021-2028 ($ MILLION)
25. CHINA SOMATOSTATIN RECEPTOR TYPE MARKET SIZE, 2021-2028 ($ MILLION)
26. JAPAN SOMATOSTATIN RECEPTOR TYPE MARKET SIZE, 2021-2028 ($ MILLION)
27. SOUTH KOREA SOMATOSTATIN RECEPTOR TYPE MARKET SIZE, 2021-2028 ($ MILLION)
28. REST OF ASIA-PACIFIC SOMATOSTATIN RECEPTOR TYPE MARKET SIZE, 2021-2028 ($ MILLION)
29. REST OF THE WORLD SOMATOSTATIN RECEPTOR TYPE MARKET SIZE, 2021-2028 ($ MILLION)
